Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status.

Saved in:
Bibliographic Details
Title: Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status.
Authors: Aspite, Silvia1 (AUTHOR), Schepis, Filippo2 (AUTHOR), Roccarina, Davide1 (AUTHOR), Gitto, Stefano1 (AUTHOR), Citone, Michele3 (AUTHOR), Di Bonaventura, Chiara1 (AUTHOR), Bianchini, Marcello2 (AUTHOR), Arena, Umberto1 (AUTHOR), Vannucchi, Alessandro M.1,4,5 (AUTHOR), Guglielmelli, Paola1,4,5 (AUTHOR), Campani, Francesca6 (AUTHOR), Fanelli, Fabrizio3 (AUTHOR), Marra, Fabio1,5 (AUTHOR), Vizzutti, Francesco1 (AUTHOR) francesco.vizzutti@unifi.it
Source: Liver International. Feb2022, Vol. 42 Issue 2, p419-424. 6p. 1 Color Photograph, 1 Chart, 1 Graph.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first